Women with PVD Frequently Misdiagnosed & Neglected, Emphasizing the Need for Further Research
The disparities between men and women in prevalence, risk factors and symptoms of peripheral vascular disease (PVD) have a profound impact on prevention, diagnosis, treatment and outcomes for women, according to a new American Heart Association scientific statement published today in the Association’s flagship, peer-reviewed journal Circulation.
FDA Approves Clinical Trials of Novel Therapy for PVD
The FDA has approved Phase 1 first in man clinical trials of Natural Vascular Scaffolding (NVS) therapy, a novel drug/device combination for the treatment of peripheral vascular disease (PVD).